0.9% Sodium Chloride Injection Shortage: Current Status and Information
Areazine synthesizes this Health Canada drug-shortage notice directly from Drug Shortages Canada's official public data feed. See our methodology for full source attribution and refresh cadence.
An active shortage of 0.9% Sodium Chloride Injection, USP has been reported by Drug Shortages Canada, affecting medical facilities and patients relying on this essential solution.
What this Health Canada drug-shortage notice tells you, and what most readers miss
This notice was issued by Drug Shortages Canada on April 6, 2026 and geographically references Canada. Its severity classification of "high" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, canada, medication, 0.9%-sodium-chloride.
What's in Shortage
Drug Name: 0.9% SODIUM CHLORIDE INJECTION, USP
Dosage Form: Injection
Current Status: Active
This medication is a sterile solution used for various medical purposes, including fluid replacement and as a vehicle for other medications.
Which Manufacturers Are Affected
According to the current report (Shortage ID: 150517), specific manufacturer names and their individual availability statuses were not provided in the source data. The report indicates an active shortage status for the drug generally.
Why There's a Shortage
No specific reason for this shortage was provided in the official report at this time.
What Patients Should Do
If you or a loved one are affected by this shortage, please consider the following steps:
- Consult Your Healthcare Provider: Speak with your doctor or clinical team about how this shortage may impact your treatment plan. They can provide guidance on the necessity of the injection and any clinical adjustments needed.
- Talk to Your Pharmacist: Pharmacists often have the most up-to-date information on local stock levels and can coordinate with suppliers or identify if specific concentrations are available.
- Monitor Official Updates: Stay informed through official health agency databases for changes in availability or anticipated end dates.
Disclaimer: Patients should always consult their healthcare provider or pharmacist regarding their specific medical needs and treatment options. Do not attempt to use alternative solutions or change your treatment without professional medical guidance.
Source
Attribution: Drug Shortages Canada (Report ID: 150517). For more details, visit the official database.
Original source: Drug Shortages Canada Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this Health Canada drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,792 characters here).
Similar severity timing
Same severity (high) notices issued closest in time to April 6, 2026.
Frequently Asked Questions
Common questions about this Health Canada drug-shortage notice.